Probiotics in current medical practice: From myths to scientific evidence

In recent years, probiotics have gained increasingly greater attention of clinicians due to their use in the prevention and treatment of multiple diseases. At the same time, the number of myths imposed by different media is also growing. The main mechanisms of action of probiotics include improvement of the mucosal barrier function, direct antagonistic activities against pathogens, inhibition of bacterial adhesion and invasion in the intestinal epithelium, enhancing of immunity and central nervous system regulation. Normal gut microbiota plays a critical role in maintaining the human health. Gut microbiota imbalance and dysbiosis may give rise to such diseases as infections, autoimmune diseases, allergies, etc. Probiotics seem to be a promising approach to the prevention and even relief of symptoms of such clinical conditions as an adjuvant therapy by preserving the normal gut microbiota balance and boosting the immunity. The present review refutes common myths that prevent from recommending and using probiotics for various indications. To date, stronger evidence in favour of their clinical use is provided in the prevention of gastrointestinal disorders, antibiotic-associated diarrhea, allergy and respiratory infections. Numerous in vitro studies, preclinical and clinical trials showed the significance of the human microbiota, improvement and restoration of its functions by probiotic treatment. In this review, we tried to summarize current knowledge on probiotics’ use and therapeutic potential in different diseases of not only digestive system, but also outside the gastrointestinal tract.

1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. https://doi.org/10.1038/nrgastro.2014.66.

2. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502. https://doi.org/10.1038/nrgastro.2017.75.

3. Hashempour-Baltork F, Sheikh M, Eskandarzadeh S, Tarlak F, Tripathi DA, Khosravi-Darani K, Sadanov A. The Effect of Probiotics on Various Diseases and their Therapeutic Role: An Update Review. J Pure Appl Microbiol. 2021;15(3):1042–1058. https://doi.org/10.22207/JPAM.15.3.17.

4. Schachtsiek M, Hammes WP, Hertel C. Characterization of Lactobacillus coryniformis DSM 20001T surface protein Cpf mediating coaggregation with and aggregation among pathogens. Appl Environ Microbiol. 2004;70(12):7078–7085. https://doi.org/10.1128/AEM.70.12.7078-7085.2004.

5. Oelschlaeger TA. Mechanisms of probiotic actions – A review. Int J Med Microbiol. 2010;300(1):57–62. https://doi.org/10.1016/j.ijmm.2009.08.005.

6. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ. 2006;175(4):377–383. https://doi.org/10.1503/cmaj.051603.

7. Schoster A, Kokotovic B, Permin A, Pedersen PD, Dal Bello F, Guardabassi L. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe. 2013;20:36–41. https://doi.org/10.1016/j.anaerobe.2013.02.006.

8. Gorelov AV, Melekhina EV, Sidel’nikova ES. Prevention of biocenosis imbalance in children with acute upper respiratory tract infection receiving antibacterial treatment. RMJ. 2019;(10):26–31. (In Russ.) Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/Profilaktika_narusheniy_biocenoza_u_detey_s_ostrymi_respiratornymi_infekciyami_poluchayuschih_antibakterialynuyu_terapiyu/.

9. Saint-Cyr MJ, Haddad N, Taminiau B, Poezevara T, Quesne S, Amelot M et al. Use of the potential probiotic strain Lactobacillus salivarius SMXD51 to control Campylobacter jejuni in broilers. Int J Food Microbiol. 2017;247:9–17. https://doi.org/10.1016/j.ijfoodmicro.2016.07.003.

10. Carter A, Adams M, La Ragione RM, Woodward MJ. Colonisation of poultry by Salmonella Enteritidis S1400 is reduced by combined administration of Lactobacillus salivarius 59 and Enterococcus faecium PXN-33. Vet Microbiol. 2017;199:100–107. https://doi.org/10.1016/j.vetmic.2016.12.029.

11. Chingwaru W, Vidmar J. Potential of Zimbabwean commercial probiotic products and strains of Lactobacillus plantarum as prophylaxis and therapy against diarrhoea caused by Escherichia coli in children. Asian Pac J Trop Med. 2017;10(1):57–63. https://doi.org/10.1016/j.apjtm.2016.12.009.

12. Hussain SA, Patil GR, Reddi S, Yadav V, Pothuraju R, Singh RRB, Kapila S. Aloe vera (Aloe barbadensis Miller) supplemented probiotic lassi prevents Shigella infiltration from epithelial barrier into systemic blood flow in mice model. Microb Pathog. 2017;102:143–147. https://doi.org/10.1016/j.micpath.2016.11.023.

13. Sikorska H, Smoragiewicz W. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents. 2013;42(6):475–481. https://doi.org/10.1016/j.ijantimicag.2013.08.003.

14. De Montijo-Prieto S, Moreno E, Bergillos-Meca T, Lasserrot A, Ruiz-López MD, Ruiz-Bravo A, Jiménez-Valera M. A Lactobacillus plantarum strain isolated from kefir protects against intestinal infection with Yersinia enterocolitica O9 and modulates immunity in mice. Res Microbiol. 2015;166(8):626–632. https://doi.org/10.1016/j.resmic.2015.07.010.

15. Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217–1231. https://doi.org/10.1542/peds.2010-2548.

16. Kumar S, Bansal A, Chakrabarti A, Singhi S. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial. Crit Care Med. 2013;41(2):565–572. https://doi.org/10.1097/CCM.0b013e31826a409c.

17. Näse L, Hatakka K, Savilahti E, Saxelin M, Pönkä A, Poussa T et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35(6):412–420. https://doi.org/10.1159/000047484.

18. Li P, Gu Q. Complete genome sequence of Lactobacillus plantarum LZ95, a potential probiotic strain producing bacteriocins and B-group vitamin riboflavin. J Biotechnol. 2016;229:1–2. https://doi.org/10.1016/j.jbiotec.2016.04.048.

19. Gu Q, Zhang C, Song D, Li P, Zhu X. Enhancing vitamin B12 content in soy-yogurt by Lactobacillus reuteri. Int J Food Microbiol. 2015;206:56–59. https://doi.org/10.1016/j.ijfoodmicro.2015.04.033.

20. Pompei A, Cordisco L, Amaretti A, Zanoni S, Matteuzzi D, Rossi M. Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol. 2007;73(1):179–185. https://doi.org/10.1128/AEM.01763-06.

21. Nova E, Wärnberg J, Gómez-Martínez S, Díaz LE, Romeo J, Marcos A. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr. 2007;98(Suppl. 1):90–95. https://doi.org/10.1017/S0007114507832983.

22. Sanders ME, Gibson GR, Gill HS, Guarner F. Probiotics: their potential to impact human health. Council for Agricultural Science and Technology Issue Paper. 2007;36:1–20. Available at: https://centaur.reading.ac.uk/13017.

23. Schellenberg J, Smoragiewicz W, Karska-Wysocki B. A rapid method combining immunofluorescence and flow cytometry for improved understanding of competitive interactions between lactic acid bacteria (LAB) and methicillinresistant S. aureus (MRSA) in mixed culture. J Microbiol Methods. 2006;65(1):1–9. https://doi.org/10.1016/j.mimet.2005.06.018.

24. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer. 2005;116(5):762–767. https://doi.org/10.1002/ijc.21115.

25. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev. 1993;12:221–238. https://doi.org/10.1111/j.1574-6976.1993.tb00020.x.

26. Guillot JF. Probiotic feed additives. J Vet Pharmacol Ther. 2003;26:52–55. Available at: https://www.scirp.org/reference/referencespapers?referenceid=3035544.

27. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 Suppl.):444S–450S. https://doi.org/10.1093/ajcn/73.2.444s.

28. Brandão RL, Castro IM, Bambirra EA, Amaral SC, Fietto LG, Tropia MJ et al. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol. 1998;64(2):564–568. https://doi.org/10.1128/AEM.64.2.564-568.1998.

29. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol. 2009;44(1):26–46. https://doi.org/10.1007/s00535-008-2296-0.

30. Chan PL, Lauw S, Ma KL, Kei N, Ma KL, Wong YO et al. ProBioQuest: a database and semantic analysis engine for literature, clinical trials and patents related to probiotics. Database. 2022;2022:baac059. https://doi.org/10.1093/database/baac059.

31. Goh A, Budijono B, Lim C, Chew EH, Yap K. An In-House Developed Probiotics Database E-Reference Information for Healthcare Professionals. Stud Health Technol Inform. 2024;310:239–243. https://doi.org/10.3233/SHTI230963.

32. Tsifintaris M, Kiousi DE, Repanas P, Kamarinou CS, Kavakiotis I, Galanis A. Probio-Ichnos: A Database of Microorganisms with In Vitro Probiotic Properties. Microorganisms. 2024;12(10):1955. https://doi.org/10.3390/microorganisms12101955.

33. Liaskovskiĭ TM, Podgorskiĭ VS. Mikrobiol Z. 2005;67(6):104–112. Available at: https://pubmed.ncbi.nlm.nih.gov/16493892.

34. Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics – a review. J Food Sci Technol. 2015;52(12):7577–7587. https://doi.org/10.1007/s13197-015-1921-1.

35. Koretz RL. Probiotics in Gastroenterology: How Pro Is the Evidence in Adults? Am J Gastroenterol. 2018;113(8):1125–1136. https://doi.org/10.1038/s41395-018-0138-0.

36. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009;9:15. https://doi.org/10.1186/1471-230X-9-15.

37. Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R et al.; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr. 2014;58(4):531–539. https://doi.org/10.1097/MPG.0000000000000320.

38. González-Rodríguez I, Sánchez B, Ruiz L, Turroni F, Ventura M, Ruas-Madiedo P et al. Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation. Appl Environ Microbiol. 2012;78(11):3992–3998. https://doi.org/10.1128/AEM.08024-11.

39. Zhu D, Sun Y, Liu F, Li A, Yang L, Meng XC. Identification of surface-associated proteins of Bifidobacterium animalis ssp. lactis KLDS 2.0603 by enzymatic shaving. J Dairy Sci. 2016;99(7):5155–5172. https://doi.org/10.3168/jds.2015-10581.

40. Wei X, Yan X, Chen X, Yang Z, Li H, Zou D et al. Proteomic analysis of the interaction of Bifidobacterium longum NCC2705 with the intestine cells Caco-2 and identification of plasminogen receptors. J Proteomics. 2014;108:89–98. https://doi.org/10.1016/j.jprot.2014.04.038.

41. Tabasco R, de Palencia PF, Fontecha J, Peláez C, Requena T. Competition mechanisms of lactic acid bacteria and bifidobacteria: fermentative metabolism and colonization. LWT Food Sci Technol. 2014;55(2):680–684. https://doi.org/10.1016/j.lwt.2013.10.004.

42. Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell. 2018;174(6):1388–1405.e21. https://doi.org/10.1016/j.cell.2018.08.041.

43. Xiao Y, Zhai Q, Zhang H, Chen W, Hill C. Gut Colonization Mechanisms of Lactobacillus and Bifidobacterium: An Argument for Personalized Designs. Annu Rev Food Sci Technol. 2021;12:213–233. https://doi.org/10.1146/annurev-food-061120-014739.

44. Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H et al. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol. 2012;46(3):220–227. https://doi.org/10.1097/MCG.0b013e31823712b1.

45. Silverman MA, Konnikova L, Gerber JS. Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea. Gastroenterol Clin North Am. 2017;46(1):61–76. https://doi.org/10.1016/j.gtc.2016.09.010.

46. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis. Antibiotics. 2017;6(4):21. https://doi.org/10.3390/antibiotics6040021.

47. Jafarnejad S, Shab-Bidar S, Speakman JR, Parastui K, Daneshi-Maskooni M, Djafarian K. Probiotics Reduce the Risk of Antibiotic-Associated Diarrhea in Adults (18–64 Years) but Not the Elderly (>65 Years): A Meta-Analysis. Nutr Clin Pract. 2016;31(4):502–513. https://doi.org/10.1177/0884533616639399.

48. Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. Multi-Strain Probiotics: Synergy among Isolates Enhances Biological Activities. Biology. 2021;10(4):322. https://doi.org/10.3390/biology10040322.

49. Toscano M, De Grandi R, Pastorelli L, Vecchi M, Drago L. A consumer’s guide for probiotics: 10 golden rules for a correct use. Dig Liver Dis. 2017;49(11):1177–1184. https://doi.org/10.1016/j.dld.2017.07.011.

50. Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr. 2011;50(1):1–17. https://doi.org/10.1007/s00394-010-0166-z.

51. Tiderencel KA, Hutcheon DA, Ziegler J. Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials. Diabetes Metab Res Rev. 2020;36(1):e3213. https://doi.org/10.1002/dmrr.3213.

52. Kianifar H, Ahanchian H, Grover Z, Jafari S, Noorbakhsh Z, Khakshour A et al. Synbiotic in the management of infantile colic: a randomised controlled trial. J Paediatr Child Health. 2014;50(10):801–805. https://doi.org/10.1111/jpc.12640.

53. Ishaque SM, Khosruzzaman SM, Ahmed DS, Sah MP. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 2018;18(1):71. https://doi.org/10.1186/s12876-018-0788-9.

54. Yala ET. The Clinical Efficacy of Multi-strain Probiotics (Protexin) in the Management of Acute Gastroenteritis in Children Two Months to Two Years Old. PIDSP Journal. 2010;11(2):86–91. Available at: http://pidsphil.org/pdf/Journal_12312011/jo39_ja05.pdf.

55. Zakharova IN, Ardatskaya MD, Sugyan NG. The Effect of Multi-Strain Probiotic on the Metabolic Activity of the Intestinal Microflora in Infants with Functional Disorders of the Gastrointestinal Tract: the Results of a Placebo-Controlled Study. Current Pediatrics. 2016;15(1):68–73. (In Russ.) https://doi.org/10.15690/vsp.v15i1.1501.

56. Mukhortykh VA, Lar’kova IA, Revyakina VA. An experience of using a multistrain probiotic in children with gastrointestinal manifestations of food allergy. Pediatric Nutrition. 2018;16(4):57–61. (In Russ.) Available at: https://www.phdynasty.ru/katalog/zhurnaly/voprosy-detskoy-dietologii/2018/tom-16-nomer-4/35206.

57. Gorelov AV, Melekhina ЕV, Sidelnikova ES. Development of pathogenetically justified approaches to therapy of young children with acute respiratory infections requiring antibacterial drugs. Meditsinskiy Sovet. 2019;(17):208–216. (In Russ.) https://doi.org/10.21518/2079-701X-2019-17-208-216.

58. Novikova VP, Magamedova DM, Blinov AE, Varlamova ON, Kondratieva AE. Mono- or multistrain probiotics? Comparative clinical study of different therapeutic strategies for infantile colic. Meditsinskiy Sovet. 2023;17(17):23–32. (In Russ.) https://doi.org/10.21518/ms2023-313.

59. Novikova VP, Magаmedova DM, Blinov AE, Varlamova ON. Clinical course of infant colic during treatment with mono- and multiprobiotics. Meditsinskiy Sovet. 2024;18(1):190–196. (In Russ.) https://doi.org/10.21518/ms2024-038.

60. Panova LD, Khismatullina ZR, Davletbayeva GA, Panova AN, Bulatova ST. Immunoprobiotic in pediatrics: from concept to practice. Meditsinskiy Sovet. 2022;16(1):212–224. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-1-212-224.

61. Zakharova IN, Koshechkin SI, Odintsova VЕ, Romanov VA, Popenko AS, Pervishko OV et al. Analysis of probiotic’s impact on the clinical manifestations and severity of acute respiratory infections. Meditsinskiy Sovet. 2024;18(11):163–172. (In Russ.) https://doi.org/10.21518/ms2024-330.

62. Plotnikova EY, Zakharova YV. Immunomodulatory effects of probiotics. Meditsinskiy Sovet. 2020;(15):135–144. (In Russ.) https://doi.org/10.21518/2079-701X-2020-15-135-144.